Clinical Trial Update: Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalated hypofractionated radiotherapy trial for prostate cancer completed phases 1 and 2 to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED